146 related articles for article (PubMed ID: 5656616)
1. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
[No Abstract] [Full Text] [Related]
2. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
Mattern J; Volm M; Wayss K
Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
[No Abstract] [Full Text] [Related]
3. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
DeWys WD; Humphreys SR; Goldin A
Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
[No Abstract] [Full Text] [Related]
4. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
Parkanskiĭ MN; Konovalova NP; Emanuél' N
Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
[No Abstract] [Full Text] [Related]
5. Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells.
Kerkvliet NI; Kimeldorf DJ
J Natl Cancer Inst; 1977 Sep; 59(3):951-5. PubMed ID: 408506
[No Abstract] [Full Text] [Related]
6. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
[No Abstract] [Full Text] [Related]
7. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
Harrison EF; Fuquay ME; Hunter HL
Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
[No Abstract] [Full Text] [Related]
8. A pilot study of antitumor effect of gallium ethylenediaminetetramethylene phosphonate [Ga(III)-EDTMP] in tumor-bearing rats.
Su M; Qiu Y; Jia W
Adv Ther; 2005; 22(4):297-306. PubMed ID: 16418139
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
10. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
Teichmann B
Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
[No Abstract] [Full Text] [Related]
11. [Antitumor activity and pharmacological properties of furizil].
Stukov AN; Kraĭz BO; Aleksandrov VA; Ivin BA; Filov VA
Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130
[TBL] [Abstract][Full Text] [Related]
12. [Screening of substances and extracts of plant origin in Walker carcinosarcoma 256].
Sampaio MR; De Oliveira MM
An Acad Bras Cienc; 1975; 47(1):149-53. PubMed ID: 1233885
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
Karaivanova MK
Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
[No Abstract] [Full Text] [Related]
14. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
Matthias M; Tanneberger S; Gummel H
Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
[No Abstract] [Full Text] [Related]
15. Antitumor effect of GPA1734 in rat Walker 256 carcinoma.
Missirlis E; Karakiulakis G; Maragoudakis ME
Invest New Drugs; 1990 May; 8(2):145-7. PubMed ID: 2384301
[TBL] [Abstract][Full Text] [Related]
16. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
Volm M; Mattern J; Weber N; Wayss K
Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
[TBL] [Abstract][Full Text] [Related]
17. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model.
Yurlova EI; Krylova SG; Dugina JL; Epstein OI
Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Walker 256 carcinosarcoma growth of dietary zinc deficiency.
DeWys W; Pories WJ; Richter MC; Strain WH
Proc Soc Exp Biol Med; 1970 Oct; 135(1):17-22. PubMed ID: 5475614
[No Abstract] [Full Text] [Related]
19. Anticarcinogenic reactivity of copper-dischiffbases with superoxide dismutase-like activity.
Miesel R; Weser U
Free Radic Res Commun; 1990; 11(1-3):39-51. PubMed ID: 2074049
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
Gold J
Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
